BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

Partners & Licensees Partnerships and licensing are a key part...

  1. scout41
    536 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    27/11/17
    06:03
    Post #: 29130710
    Partners & Licensees

    Partnerships and licensing are a key part of REGENXBIO’s commitment to enabling the ongoing development of gene therapy treatments using our NAV Technology Platform. Our NAV Technology Platform is being applied in the development of over 20 partnered product candidates for a variety of diseases by our NAV Technology Licensees.
    Please contact us to discuss partnering or licensing opportunities.


    BLT Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.